IPSS-R Risk Category LowNCIt concept

https://minerva-ebp.be/FR/Article/2364
2024
Belgium
critical appraisal or critical reading
opiate agonist, nos
opioids
low back pain
Behavioral Activation Intervention to Smoking Cessation and to Post-Cessation Weight Gain
Opioid
Bladder Neck
Lower
Low Mitosis-Karyorrhexis Index
Low Calcium Level
Malignant Germ Cell International Collaborative Risk Classification, Low
Back
pain, nos
analgesics, opioid
neck pain
Serum CA 19-9 Low
Murine Back
Bottom
neck
back
Neck of the Pancreas
IPSS-R Risk Category Low
Acute Pain
Trough Concentration
Serum CEA Level Low
Low LDH Level
acute pain
Value Below Reference Range
Lowest
IPSS Risk Category Low
Murine Neck
Low Level
What Month is it
Neck
GDC Biospecimen Anatomic Site Terminology

---
https://conseil-scientifique.public.lu/fr/publications/perinat/suivi-de-la-grossesse-normale-et-a-bas-risque-en-secteur-hospitalier-ou-extra-hospitalier.html
2024
Luxembourg
practice guideline
Lower
Bottom
Behavioral Activation Intervention to Smoking Cessation and to Post-Cessation Weight Gain
Clinical Study Follow-up
Follow
risk
Serum CA 19-9 Low
Low Level
Low Calcium Level
Low Mitosis-Karyorrhexis Index
hospital, nos
Lowest
Malignant Germ Cell International Collaborative Risk Classification, Low
Sector
normal pregnancy
pregnancy, high-risk
Supernumerary
Value Below Reference Range
IPSS-R Risk Category Low
IPSS Risk Category Low
Normal Pregnancy
pregnancy
Low LDH Level
aftercare
Serum CEA Level Low
GDC Biospecimen Anatomic Site Terminology
hospitals

---
https://www.inesss.qc.ca/fileadmin/doc/INESSS/Rapports/Biologie_medicale/INESSS_Pertinence_tests_preop_GUO.pdf
2024
Canada
practice guideline
People
Drug Accumulation 1.2 to 1.99
More
Low Risk
American Samoa
Sixteen
International Prognostic Index Low Risk Group
Autonomic Nervous System
Human Papillomavirus-16
Disease Risk Index Low Risk
American College of Cardiology/American Heart Association Lesion Complexity Score A
risk
persons
asthenia
Elective Surgical Procedures
IPSS-R Risk Category Low
operative procedure, nos
Elective Surgical Procedure

---
https://www.cochrane.org/fr/CD014715/PREG_precision-de-lechographie-du-premier-et-du-deuxieme-trimestre-pour-lidentification-des-anomalies
2024
United Kingdom
review of literature
french abstract
Intervention Not Given for Kawasaki Disease
KIT Mutation Analysis Was Not Performed
Lymph Node Dissection Was Not Performed
Unemployed
Nitric Oxide Measurement
American College of Cardiology/American Heart Association Lesion Complexity Score A
NF1 Mutation Analysis Was Not Performed
Use of Smokeless Tobacco at Time of Diagnosis Negative
History of Medical Treatment Absent
Has No Sibling
Additional Surgery for New Tumor Event Absent
Tumor Reoccurrence Absent After Initial Treatment
First Trimester
Adjuvant Post-operative Immunological Therapy Was Not Administered
Accuracy
IDH Family Wildtype
asthenia
First Degree Family History Cancer Negative
Regional Anesthesia was not Administered
Choose
Drug Accumulation 1.2 to 1.99
International Prognostic Index Low Risk Group
Medication Not Taken
Interferon Gamma Treatment was not Administered Prior to Specimen Resection
No History of Gestational Complication
Tumor Progression Absent After Initial Treatment
No History of Congenital Heart Disease
Pregnancy
Ultrasound Mode
Interferon Gamma Treatment was not Administered 90 Days Prior to Specimen Resection
Additional Molecular Studies Were Not Performed
Radiation Was Not Administered as an Additional Treatment for a New Tumor Event
NON Mouse
IV Anesthesia was not Administered
No History of Other Muscular Dystrophy or Glycogen Storage Disorder
RET Rearrangement Analysis Was Not Performed
pregnancy trimester, first
Not Lost to Follow-Up
Patient was not Postmenopausal with no Prior Oophorectomy
Ultrasound
De-Identification
Chief Complaint was Not Witnessed
ERBB2 Mutation Analysis Was Not Performed
Peripheral Blood Immunophenotyping and Cytochemistry Were Not Performed
New Tumor Event After Initial Treatment Absent
No History of Kawasaki Disease
Routine Cytogenetics Were not Completed
EGFR Gene Amplification Negative
fetus, nos
Subsequent Known Primary Melanoma(s) Not Found During the Follow-Up
Adjuvant Post-operative Radiation Therapy Was Not Administered
Adjuvant Post-operative Pharmaceutical Therapy Was Not Administered
ultrasonography, nos
ALK Rearrangement Analysis Was Not Performed
Bone Marrow Aspirate Immunophenotyping and Cytochemistry Were Not Performed
pregnancy
Adjuvant Post-operative Targeted Molecular Therapy Was Not Administered
Minor Criteria for Rheumatic Heart Disease Not Present
defect, nos
Chemical/Occupational Exposure Absent
PTEN Gene Mutation Negative
Neither Case or Control Status
IDH Family Mutation Analysis Was Not Performed
No History of Myopathy
Cancer History Absent
No Response to Intervention for Kawasaki Disease
Low Risk
Evidence of Disease Absent after Completion of Therapy
Documentation Absent
fetal ultrasonography
Caffeine Not Routinely Consumed
Family History of Stomach Cancer Absent
pregnancy, high-risk
Therapeutic Ionizing Radiation to Head History Absent
MET Mutation Analysis Was Not Performed
Abnormality
EGFR Amplification Analysis Was Not Performed
ATRX Mutation Analysis Was Not Performed
Chemotherapy Was Not Administered as an Additional Treatment for a New Tumor Event
Norway
pregnancy, nos
Chemotherapy Not Received
Other Preoperative IV Medications were not Administered
Analytical Procedure Precision
Regardless
First Degree Family History Thyroid Cancer Negative
No Known History of Illicit Drug Use
Patient was Not Previously Evaluated for Current Chief Complaint
Exposure as Collected Occurrence
SDH Complex Mutation Analysis Was Not Performed
Negation
No History of Neonatal Complication
Molecular Genetic Variation
Immunotherapy Was Not Administered as an Additional Treatment for a New Tumor Event
Preoperative IV Antiemetics were not Administered
Ultrasonogram
Fluorescence In Situ Hybridization Was Not Performed
Abnormal Indicator
ATRX Gene Mutation Negative
New Disease is not Multifocal
Selenium and Vitamin E Efficacy Trial
First Degree Family History of Primary Brain Tumor Negative
Fetus
Petal
Neither
Ultrasound Imaging
Adjuvant I-131 Therapy Negative
PDGFRA Mutation Analysis Was Not Performed
Preoperative IV Antacids were not Administered
Radiation History Negative
Targeted Molecular Therapy Was Not Administered as an Additional Treatment for a New Tumor Event
ultrasonography, prenatal
Intercurrent Illness is Absent at Onset of Chief Complaint
Multiple Known Primary Tumors Absent at Initial Melanoma Diagnosis
Unspecified
History of Colorectal Cancer Negative
Any Metastatic Diagnosis Absent
1p/19q Deletion Analysis Was Not Performed
Chief Complaint Not Caused by Trauma
Another Form of Birth Control was not Used
No Known History of Alcohol Use
Hypertension Absent
Radiation Therapy Not Received
IPSS-R Risk Category Low
Local Anesthesia Agents were not Administered
Preoperative IV Sedation was Not Administered
EGFR Mutation Analysis Was Not Performed
PTEN Mutation Analysis Was Not Performed
Paraneoplastic Syndrome is Not Present
Preoperative IV Opiates were not Administered
TP53 Mutation Analysis Was Not Performed
Nitric Oxide
Additional Surgery for New Loco-Regional Tumor Event Was Not Performed
MGMT Promoter Methylation Testing Was Not Performed
Hormone Therapy Was Not Administered as an Additional Treatment for a New Tumor Event
BRAF Rearrangement Analysis Was Not Performed
ROS1 Rearrangement Analysis Was Not Performed
Additional Immunohistochemistry Was Not Performed
Disease Risk Index Low Risk
NRAS Mutation Analysis Was Not Performed
No History of Rheumatic Fever
No History of Non-Cardiac Surgery
KRAS Mutation Analysis Was Not Performed
Adjuvant Post-operative Chemotherapy Was Not Administered
Regular Smokeless Tobacco Use for Six Weeks or More Negative
risk
Analytical Procedure Accuracy
Physician Diagnosed Diabetes Absent
10q23/PTEN Locus Deletion Analysis Was Not Performed
BRAF Mutation Analysis Was Not Performed
Additional Surgery for New Metastatic Tumor Event Was Not Performed

---
https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/pertinence-des-consultations-et-tests-preoperatoires-pour-une-chirurgie-elective-a-faible-risque-chez-les-personnes-de-16-ans-et-plus.html
2024
Canada
guideline
Consultation
International Prognostic Index Low Risk Group
Disease Risk Index Low Risk
IPSS-R Risk Category Low
Low Risk
operative procedure, nos
Autonomic Nervous System
Elective Surgical Procedures
Sixteen
Elective Surgical Procedure
asthenia
Drug Accumulation 1.2 to 1.99
American Samoa
American College of Cardiology/American Heart Association Lesion Complexity Score A
persons
People
More
Human Papillomavirus-16
referral and consultation
Laboratory Procedure
consultants
risk

---
https://minerva-ebp.be/FR/Analysis/848
2023
Belgium
critical appraisal or critical reading
attentiveness
Malignant Germ Cell International Collaborative Risk Classification, Low
Data Port
Status Post
thrombus, nos
postthrombotic syndrome
Dronabinol
IPSS Risk Category Low
Bottom
Illinois
As Needed
Serum CA 19-9 Low
What Month is it
stockings, compression
Israel
deep thrombophlebitis, nos
Low Calcium Level
Lowest
Ropinirole Hydrochloride
mannerism
Lower
Value Below Reference Range
Low Mitosis-Karyorrhexis Index
During or After
Serum CEA Level Low
deep vein thrombosis
Low Level
Interleukin
GDC Biospecimen Anatomic Site Terminology
Deep Vein Thrombosis
IPSS-R Risk Category Low
Adverse Event Associated with Syndromes
Low LDH Level
Behavioral Activation Intervention to Smoking Cessation and to Post-Cessation Weight Gain

---
https://minerva-ebp.be/FR/Analysis/832
2023
Belgium
critical appraisal or critical reading
Nonclinical Randomization
choice behavior
Localized Malignant Neoplasm
case study
malignant neoplasm prostate
Locally Advanced Malignant Neoplasm
prostatic neoplasms
Cancer Risk
prostate cancer
survival
general surgery
neoplasm, malignant
International Prognostic Index Low Risk Group
American College of Cardiology/American Heart Association Lesion Complexity Score A
resulting in
Long-Term
Prostate Cancer Outcomes Study
radiotherapy
Drug Accumulation 1.2 to 1.99
asthenia
activir
Similarity
Patient Observation
operative procedure, nos
snacks
watchful waiting
Case Series
risk
sampling studies
Case Study
IPSS-R Risk Category Low
radiation therapy, nos
Low Risk
outcome studies
Therapeutic Skin Surgery
X-ray Therapy
prostate, nos
Disease Risk Index Low Risk
Choose
Cancer Survivorship Research
therapeutics

---
https://dumas.ccsd.cnrs.fr/dumas-03999150
2023
France
dissertations, academic
Twelve
Algeria
Behavioral Activation Intervention to Smoking Cessation and to Post-Cessation Weight Gain
screening
Lowest
Low Calcium Level
Medication
Screening for Skin Cancer
Lower
Value Below Reference Range
medicine
IPSS Risk Category Low
Low LDH Level
Serum CEA Level Low
Screening Study
Bottom
Low Mitosis-Karyorrhexis Index
GDC Biospecimen Anatomic Site Terminology
mass screening
general practitioners
Malignant Germ Cell International Collaborative Risk Classification, Low
Serum CA 19-9 Low
skin, nos
IPSS-R Risk Category Low
Low Level
qualitative research

---